Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma
J Vasc Interv Radiol
.
2019 Dec;30(12):2047-2048.
doi: 10.1016/j.jvir.2019.08.030.
Epub 2019 Oct 30.
Authors
Stephan Walrand
1
,
Carlo Chiesa
2
,
Pablo Minguez Gabina
3
,
Nicolas Chouin
4
,
Jonathan Gear
5
,
Caroline Stokke
6
,
Peter Bernhardt
7
,
Katarina Sjogreen Gleisner
8
,
Lidia Strigari
9
,
Mark Konijnenberg
10
;
EANM Dosimetry Committee
Affiliations
1
Nuclear Medicine, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium.
2
Nuclear Medicine, Foundation Istituto di Ricovero e Cura a Carattere Scientifico National Tumour Institute Milan, Italy.
3
Department of Medical Physics and Radiation Protection, Gurutzeta/Cruces University Hospital Barakaldo, Spain.
4
Oniris, Cancers Animaux, Modèle pour la Recherche en Oncologie Comparée, L'Université Nantes Angers Le Mans, Nantes, France.
5
Joint Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom.
6
Department of Diagnostic Physics Oslo University Hospital, Oslo, Norway.
7
Department of Radiation Physics, Göteborg University, Sahlgrenska University Hospital Gothenburg, Sweden.
8
Department of Medical Radiation Physics, Clinical Sciences Lund, Lund University Lund, Sweden.
9
Department of Medical Physics, St. Orsola Malpighi University Hospital Bologna, Italy.
10
Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
PMID:
31676203
DOI:
10.1016/j.jvir.2019.08.030
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular*
Embolization, Therapeutic*
Humans
Liver Neoplasms*
Microspheres
Yttrium Radioisotopes
Substances
Yttrium Radioisotopes
Yttrium-90